Literature DB >> 8605335

Xenogeneic expression of human stem cell factor in transgenic mice mimics codominant c-kit mutations.

M K Majumdar1, E T Everett, X Xiao, R Cooper, K Langley, R Kapur, T Vik, D A Williams.   

Abstract

Mutations of c-kit, which encodes a transmembrane receptor tyrosine kinase, have been identified in mice by abnormal coat color, anemia, and germ cell defects. Mice heterozygous for mutations of c-kit have a white forehead blaze and a white ventral spot, leading these mutants to be termed dominant White spotting (W). We have previously demonstrated that the membrane-associated isoform of human stem cell factor (hSCF220, the ligand for c-kit) is inefficiently processed in murine stromal cell transfectants. Thus, in murine cell lines analyzed in vitro, hSCF220 transfectants present SCF as a membrane restricted protein in contrast to the murine SCF220 cDNA protein product, which is slowly cleaved and secreted. We show here that transgenic mice expressing the human SCF220 isoform in vivo display a phenotype indistinguishable from some alleles of W. Specifically, hSCF220-expressing transgenic mice display a prominent forehead blaze and a white ventral spot. Generations of doubly heterozygous animals that carry both a mutated c-kit allele and the hSCF220 transgene display a more severe coat color abnormality. This phenotype appears to be due to occupancy of murine c-kit by human SCF and diminished cell surface expression of endogenous murine SCF. Normal signaling events that lead to cell survival or proliferation appear to be disrupted in vivo in these transgenic mice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605335

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation.

Authors:  Shinsuke Takagi; Yoriko Saito; Atsushi Hijikata; Satoshi Tanaka; Takashi Watanabe; Takanori Hasegawa; Shinobu Mochizuki; Jun Kunisawa; Hiroshi Kiyono; Haruhiko Koseki; Osamu Ohara; Takashi Saito; Shuichi Taniguchi; Leonard D Shultz; Fumihiko Ishikawa
Journal:  Blood       Date:  2012-01-25       Impact factor: 22.113

2.  Engraftment of human HSCs in nonirradiated newborn NOD-scid IL2rγ null mice is enhanced by transgenic expression of membrane-bound human SCF.

Authors:  Michael A Brehm; Waldemar J Racki; Jean Leif; Lisa Burzenski; Vishnu Hosur; Amber Wetmore; Bruce Gott; Mary Herlihy; Ronald Ignotz; Raymond Dunn; Leonard D Shultz; Dale L Greiner
Journal:  Blood       Date:  2012-01-12       Impact factor: 22.113

3.  A xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti-IL-6R treatment.

Authors:  Mark Wunderlich; Courtney Stockman; Mahima Devarajan; Navin Ravishankar; Christina Sexton; Ashish R Kumar; Benjamin Mizukawa; James C Mulloy
Journal:  JCI Insight       Date:  2016-09-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.